Tamaño y pronóstico del mercado de Tratamiento de infecciones del tracto respiratorio de MEA (2021-2031), cobertura del informe de análisis de participación regional, tendencias y oportunidades de crecimiento: por medicamento (antibióticos, AINE, antitusígenos, descongestionantes nasales y otros), indicación de enfermedad (tracto respiratorio superior) Infección e infección del tracto respiratorio inferior), vía de administración (oral y parenteral), grupo de edad (pediátrico y de adultos), canal de distribución (farmacias hospitalarias, farmacias en línea y farmacias minoristas) y país.

Se espera que el tamaño del mercado de tratamiento de infecciones del tracto respiratorio de MEA crezca de 2,09 mil millones de dólares en 2023 a 2,97 mil millones de dólares en 2031; se estima que registrará una tasa compuesta anual del 4,50% de 2023 a 2031. Aumento de la demanda de productos de venta libre para tratar infecciones respiratorias Oportunidad de crecimiento del mercado de tratamiento de infecciones del tracto respiratorio MEA Un gran número de consumidores busca soluciones accesibles y convenientes para síntomas respiratorios comunes como como tos, congestión y dolor de garganta. Este enfoque permite a las personas que no padecen enfermedades potencialmente mortales vigilar y controlar de cerca su salud. También permite a los fabricantes, farmacias y proveedores de atención médica hacer que sus ofertas de productos sean más adecuadas para aplicaciones de venta libre (OTC), educar a los consumidores sobre prácticas de cuidado personal y mejorar el acceso a opciones de tratamiento que alivien diversos síntomas. La creciente popularidad de los remedios respiratorios de venta libre subraya la importancia de promover la concientización sobre la salud respiratoria, fomentar estrategias de autocuidado y un ecosistema de atención médica colaborativa. Al aprovechar la creciente popularidad de los productos respiratorios de venta libre, las partes interesadas del mercado de tratamiento de infecciones del tracto respiratorio en MEA pueden mejorar la participación de los pacientes, promover medidas de atención médica preventiva y abordar las necesidades de atención médica en evolución de diversas poblaciones. Por lo tanto, la creciente demanda de productos de venta libre para controlar las infecciones respiratorias representa una oportunidad importante para el mercado de tratamiento de infecciones del tracto respiratorio de MEA. Información basada en medicamentos En términos de medicamentos, el segmento de antibióticos tuvo la mayor participación de mercado de tratamiento de infecciones del tracto respiratorio de MEA en 2023. Se prevé que lo mismo registre la CAGR más alta durante 2023-2031. Las infecciones del tracto respiratorio abarcan una variedad de dolencias, que incluyen bronquitis, neumonía y sinusitis, a menudo causadas por patógenos bacterianos. Información basada en indicaciones de enfermedades Según la indicación de enfermedades, el segmento de infecciones del tracto respiratorio inferior tuvo una mayor participación de mercado en 2023. Además, se prevé que registre una CAGR más alta de 2023 a 2031. Las infecciones del tracto respiratorio inferior (LRTI) son infecciones que afectan el pulmones y bronquios, típicamente causados por patógenos bacterianos, virales o fúngicos, entre otros. Información basada en la vía de administración Por vía de administración, el segmento oral tenía una participación mayor en el mercado de tratamiento de infecciones del tracto respiratorio de MEA; Se prevé que el mismo segmento registre una CAGR más alta durante 2023-2031. Con frecuencia se recetan antibióticos orales como amoxicilina, azitromicina o doxiciclina para combatir los patógenos bacterianos que causan infecciones del tracto respiratorio. Información basada en grupos de edad En términos de grupo de edad, el segmento de adultos tuvo una mayor participación en el mercado de tratamiento de infecciones del tracto respiratorio de MEA en 2023. Se prevé que el segmento de pediatría registre una CAGR más alta durante 2023-2031. La alta prevalencia de infecciones del tracto respiratorio entre los niños es un factor clave que impulsa la necesidad de opciones de tratamiento eficaces. Información basada en el canal de distribución En términos de canal de distribución, se prevé que el segmento de farmacias hospitalarias represente una participación de mercado significativa durante 2023-2031. Las farmacias hospitalarias sirven como componentes clave de un sistema de salud; En particular, desempeñan un papel vital en el tratamiento de infecciones agudas y graves del tracto respiratorio, que requieren la administración de medicamentos por vía intravenosa o intramuscular. Algunas de las principales fuentes primarias y secundarias a las que se hizo referencia al preparar el informe sobre el mercado de tratamiento de infecciones del tracto respiratorio de MEA son la Autoridad Sanitaria de Dubai, la Iniciativa Saudita para el Asma y la Sociedad Torácica Saudita.

Table of Contents

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Respiratory Tract Infection Treatment Market Landscape

4.1 Overview

4.2 PEST Analysis

5. MEA Respiratory Tract Infection Treatment Market - Key Market Dynamics

5.1 MEA Respiratory Tract Infection Treatment Market - Key Market Dynamics

5.2 Key Market Drivers

5.2.1 Rising Cases of Respiratory Infections in Middle East

5.2.2 Increasing Awareness Related to Respiratory Tract Infections

5.3 Key Market Restraints

5.3.1 Lack of Research Focused on Respiratory Therapeutics

5.4 Key Market Opportunities

5.4.1 Surge in Demand for OTC Products to Treat Respiratory Infections

5.5 Future Trends

5.5.1 Advent of Antiviral Treatment for MERS

5.6 Impact of Drivers and Restraints:

6. MEA Respiratory Tract Infection Treatment Market Analysis

6.1 MEA Respiratory Tract Infection Treatment Market Revenue (US$ Million), 2023-2031

7. MEA Respiratory Tract Infection Treatment Market Analysis - by Drugs

7.1 Antibiotics

7.1.1 Overview

7.1.2 Antibiotics: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

7.2 NSAIDs

7.2.1 Overview

7.2.2 NSAIDs: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

7.3 Cough Suppressants

7.3.1 Overview

7.3.2 Cough Suppressants: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

7.4 Nasal Decongestants

7.4.1 Overview

7.4.2 Nasal Decongestants: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

8. MEA Respiratory Tract Infection Treatment Market Analysis - by Disease Indication

8.1 Lower Respiratory Tract Infection

8.1.1 Overview

8.1.2 Lower Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

8.2 Upper Respiratory Tract Infection

8.2.1 Overview

8.2.2 Upper Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

9. MEA Respiratory Tract Infection Treatment Market Analysis - by Route Of Administration

9.1 Oral

9.1.1 Overview

9.1.2 Oral: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

9.2 Parenteral

9.2.1 Overview

9.2.2 Parenteral: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

10. MEA Respiratory Tract Infection Treatment Market Analysis - by Age Group

10.1 Pediatrics

10.1.1 Overview

10.1.2 Pediatrics: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

10.2 Adults

10.2.1 Overview

10.2.2 Adults: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

11. MEA Respiratory Tract Infection Treatment Market Analysis - by Distribution Channel

11.1 Hospital Pharmacies

11.1.1 Overview

11.1.2 Hospital Pharmacies: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

11.2 Retail Pharmacies

11.2.1 Overview

11.2.2 Retail Pharmacies: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

11.3 Online Pharmacies

11.3.1 Overview

11.3.2 Online Pharmacies: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

12. MEA Respiratory Tract Infection Treatment Market - Country Analysis

12.1 Middle East and Africa

12.1.1 MEA Respiratory Tract Infection Treatment Market Breakdown by Countries

12.1.2 MEA Respiratory Tract Infection Treatment Market Revenue and Forecast and Analysis - by Country

12.1.3 MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2030

12.1.3.1 MEA Respiratory Tract Infection Treatment Market Revenue and Forecast and Analysis - by Country

12.1.3.2 Saudi Arabia

12.1.3.3 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

12.1.3.3.1 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs

12.1.3.3.2 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication

12.1.3.3.3 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration

12.1.3.3.4 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group

12.1.3.3.5 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel

12.1.3.4 South Africa

12.1.3.5 South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

12.1.3.5.1 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs

12.1.3.5.2 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication

12.1.3.5.3 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration

12.1.3.5.4 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group

12.1.3.5.5 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel

12.1.3.6 UAE

12.1.3.7 UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

12.1.3.7.1 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs

12.1.3.7.2 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication

12.1.3.7.3 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration

12.1.3.7.4 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group

12.1.3.7.5 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel

12.1.3.8 Rest of MEA

12.1.3.9 REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

12.1.3.9.1 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs

12.1.3.9.2 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication

12.1.3.9.3 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration

12.1.3.9.4 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group

12.1.3.9.5 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Teva Pharmaceutical Industries Ltd

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Sanofi SA

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Boehringer Ingelheim International GmbH

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 AstraZeneca Plc

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Alembic Pharmaceuticals Ltd

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 GSK Plc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Novartis AG

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 F. Hoffmann-La Roche Ltd

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Gulf Pharmaceutical Industries Co

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

List of TablesTable 1. MEA Respiratory Tract Infection Treatment Market Segmentation

Table 2. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs

Table 3. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication

Table 4. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration

Table 5. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group

Table 6. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 7. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Country

Table 8. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs

Table 9. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication

Table 10. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration

Table 11. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group

Table 12. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 13. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs

Table 14. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication

Table 15. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration

Table 16. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group

Table 17. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 18. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs

Table 19. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication

Table 20. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration

Table 21. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group

Table 22. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 23. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs

Table 24. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication

Table 25. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration

Table 26. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group

Table 27. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 28. Glossary of Terms, MEA Respiratory Tract Infection Treatment Market

List of Figures

Figure 1. MEA Respiratory Tract Infection Treatment Market Segmentation, by Country

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. MEA Respiratory Tract Infection Treatment Market Revenue (US$ Million), 2023-2031

Figure 5. MEA Respiratory Tract Infection Treatment Market Share (%) - by Drugs, 2023 and 2031

Figure 6. Antibiotics: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 7. NSAIDs: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 8. Cough Suppressants: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 9. Nasal Decongestants: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 10. MEA Respiratory Tract Infection Treatment Market Share (%) - by Disease Indication, 2023 and 2031

Figure 11. Lower Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 12. Upper Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 13. MEA Respiratory Tract Infection Treatment Market Share (%) - by Route Of Administration, 2023 and 2031

Figure 14. Oral: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 15. Parenteral: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 16. MEA Respiratory Tract Infection Treatment Market Share (%) - by Age Group, 2023 and 2031

Figure 17. Pediatrics: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 18. Adults: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 19. MEA Respiratory Tract Infection Treatment Market Share (%) - by Distribution Channel, 2023 and 2031

Figure 20. Hospital Pharmacies: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 21. Retail Pharmacies: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 22. Online Pharmacies: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 23. MEA Respiratory Tract Infection Treatment Market Breakdown by Key Countries, 2023 and 2031 (%)

Figure 24. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2030(US$ Million)

Figure 25. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

Figure 26. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

Figure 27. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

Figure 28. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

The List of Companies - MEA Respiratory Tract Infection Treatment Market

Abbott Laboratories

AstraZeneca plc

Alembic Pharmaceuticals Ltd.

Boehringer Ingelheim International GmbH

GlaxoSmithKline plc

Teva Pharmaceutical Industries Ltd

Novartis AG

F. Hoffmann-La Roche AG

Sanofi S.A.

Orion Corporation

Julphar

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA Respiratory Tract Infection Treatment Market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the MEA Respiratory Tract Infection Treatment Market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth market trends and outlook coupled with the factors driving the MEA Respiratory Tract Infection Treatment Market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
MEA Logistics Market Forecast to 2028 -COVID-19 Impact and Analysis by Model (1PL, 2PL, 3PL, 4PL, Cold Chain, Secure Logistics, and Last Mile Delivery..	Apr 2022
MEA N95 Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (With Exhalation Valve and Without Exhalation Valve), Distrib..	Oct 2021
Middle East and Africa Variable Speed Drive Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Voltage (Low Voltage and Medium Voltage..	Sep 2021

Purchase Options

Single User License

$3550

$2840

Site License

$4550

$3640

Enterprise License

$5550

$4440

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Get Free Sample For MEA Respiratory Tract Infection Treatment Market

WHAT'S INCLUDED IN FULL REPORT